Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03033966
Other study ID # Item No.6.04, Neurosciences
Secondary ID
Status Completed
Phase N/A
First received January 25, 2017
Last updated January 26, 2017
Start date February 10, 2016
Est. completion date June 30, 2016

Study information

Verified date January 2017
Source National Institute of Mental Health and Neuro Sciences, India
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Cerebral hypoperfusion and hypoxia are the major determinants of neurological outcomes following acute brain injury as proved in Traumatic Brain Injury/Sub Arachnoid Haemhorrhage literature. How the brain injury affects cerebral oxygenation in patients with CVT is not currently known. Some of the factors that can affect cerebral oxygenation in patients with CVT are Hemoglobin, PO2, PCO2, Cerebral Perfusion Pressure (or MAP) and change in Intracranial Pressure after Decompressive Craniectomy. This study is designed to study how these factors affect cerebral oxygenation and impact of Decompressive Craniectomy on the cerebral oxygenation.


Recruitment information / eligibility

Status Completed
Enrollment 17
Est. completion date June 30, 2016
Est. primary completion date June 30, 2016
Accepts healthy volunteers No
Gender All
Age group 16 Years to 65 Years
Eligibility Inclusion Criteria:

-Patients diagnosed with cerebral venous thrombosis, undergoing decompressive craniectomy.

Exclusion Criteria:

- Patients on inotropic support

- Systolic blood pressure < 90 mmHg

- Haemoglobin oxygen saturation <95%

- Refusal of consent

- Age <16 and > 65 years

- Known history of diabetes or hypertension

- Pregnancy

- Any contraindication for application of cerebral oximetry sensors

Study Design


Related Conditions & MeSH terms


Intervention

Device:
NIRS based Cerebral Oximetry
Cerebral Oximetric measurement before and after decompressive craniectomy

Locations

Country Name City State
India NIMHANS Bangalore City Karnataka

Sponsors (1)

Lead Sponsor Collaborator
Dhritiman Chakrabarti

Country where clinical trial is conducted

India, 

Outcome

Type Measure Description Time frame Safety issue
Primary Ipsilateral Regional Cerebral Oxygen Saturation Measurement of regional cerebral oxygen saturation over ipsilateral frontal lobe before and after decompressive craniectomy with follow up at postoperative 24 and 48 hours. From Recruitment till 48 hours postoperative (end of study)
Secondary Contralateral Regional Cerebral Oxygen Saturation Measurement of regional cerebral oxygen saturation over contralateral frontal lobe before and after decompressive craniectomy with follow up at postoperative 24 and 48 hours. From Recruitment till 48 hours postoperative (end of study)
Secondary Systolic Blood Pressure Measurement of systolic blood pressure before and after decompressive craniectomy with follow up at postoperative 24 and 48 hours. From Recruitment till 48 hours postoperative (end of study)
Secondary Glasgow coma scale score Measurement of Glasgow coma scale score before and after decompressive craniectomy with follow up at postoperative 24 and 48 hours. From Recruitment till 48 hours postoperative (end of study)
Secondary Arterial blood gas measurement Arterial blood gas measurement before and after decompressive craniectomy with follow up at postoperative 24 and 48 hours. From Recruitment till 48 hours postoperative (end of study)
Secondary Haemoglobin Haemoglobin measurement before and after decompressive craniectomy with follow up at postoperative 24 and 48 hours. From Recruitment till 48 hours postoperative (end of study)
See also
  Status Clinical Trial Phase
Completed NCT00924859 - The Role of Factor XIII Activation Peptide and D-dimer Values for the Diagnosis of Cerebral Venous Thrombosis (CVT)
Recruiting NCT03747081 - Efficacy Comparison of Warfarin Versus Rivaroxaban CVT Phase 1/Phase 2
Recruiting NCT03217448 - The Efficacy and Safety of Dabigatran Etexilate for the Treatment of Cerebral Venous Thrombosis Phase 3
Recruiting NCT04660747 - Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis
Completed NCT03178864 - Study of Rivaroxaban for CeREbral Venous Thrombosis Phase 2
Recruiting NCT04972058 - Philippine Neurological Association One Database - Stroke
Completed NCT02013635 - Thrombin Generation and Thrombus Degradation in Cerebral Venous Thrombosis : Clinical and Radiological Correlations N/A
Completed NCT06266585 - Clinical Deterioration in Cerebral Venous Thrombosis: A Predictive Study
Completed NCT05990894 - Steroid for Treatment of Acute/Subacute Severe Cerebral Venous Thrombosis.
Not yet recruiting NCT03191305 - Comparison of the Efficacy of Rivroxaban to Coumadin( Warfarin ) in Cerebral Venous Thrombosis N/A
Recruiting NCT05491980 - Florida Cerebrovascular Disease Biorepository and Genomics Center
Completed NCT01796015 - Intracranial Hypertension and Optic Nerve Sheath Diameter N/A